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ABSTRACT 
Aim: The study was set to assess the relationship between antioxidant status, smoking 
and hypertension, the argument being whether there would be a significant difference in 
antioxidant status and perhaps, a significant difference in blood pressure.  
Methods: A total of105 samples were collected. 36 samples were collected from type I 
hypertensive smokers; 47 from hypertensive non smokers, the remaining 22 were 
collected from normal non smokers, who served as control. The blood pressure of each 
subject was measured. Determinations of SOD activity and TBARS content were 
carried out on each of the samples. Determination of systolic and diastolic blood 
pressure was also carried out using a digital sphygmomanometer. The results of all 
investigations were thereafter subjected to statistical analysis using SPSS 17, the 
student’s t test being the tool of choice. Significance was tested at P<0.05.  
Results: The mean systolic and diastolic blood pressureof hypertensive smokers and 
non smokinghypertensives was found to be significantly increased. Similarly the mean 
systolic and diastolic blood pressure of hypertensive smokers was found to be 
significantly increased. SOD activity was significantly decreased while TBARS levels 
were significantly higher in both hypertensive groups. Lipid peroxidation was 
significantly higher while SOD activity was significantly lower in hypertensive smokers 
when compared with hypertensive non smokers 
Conclusion: It appears that cigarette smoking as a social lifestyle depletes SOD levels 
but increases lipid peroxidation. It also seems to favour the progression of essential 
hypertension from mild to severity. 
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INTRODUCTION  
Hypertension (HTN) or high blood pressure 
(HBP) is a chronic medical condition in which 
the blood pressure in the arteries is elevated. It is 
classified as either primary (essential) or 
secondary. Majority of cases are termed primary 
or idiopathic hypertension, which refers to high 
BP for which no medical cause can be found 
(Carreteroand Oparil, 2000).  The remaining 5 to 
10% of cases, called secondary HTN, are caused 
by other conditions that affect the kidneys, 
arteries, heart, or endocrine system(Beeversetal., 
2001). Persistent HTN is one of the risk factors 
for strokes, heart attacks, heart failure, and 
arterial aneurysm, and is a leading cause of 
chronic kidney failure(Pierdomenico et al., 
2009).Cigarette smoking on the other hand is a 
social habit that has been described as a lifestyle 
Factor that affects the health of humans (Alharbi, 
2012). The habit of tobacco smoking starts 
during the period of adolescence or early 
adulthood as teenagers are attracted more by 
their peers than by the adults (Harris, 1998). 
There are numerous harmful substances found in 
tobacco and tobacco smoke (Proctor, 2012). The 
Cigarette smoke reaches quickly to heart, brain 
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and other parts of our body, and may cause 
effects in less than a second as it is inhaled 
directly into the alveoli and is diffused into the 
pulmonary vein (Alharbi, 2012). Reactive 
oxygen species (ROS) can be defined as reactive 
derivatives of O2 metabolism. They exist in the 
environment and in all biological systems. In 
healthy conditions, ROS are produced in a 
controlled manner at low concentrations and 
function as signaling molecules (Touyzand 
Schiffrin, 2004). Important  ROS detectable 
within the vasculature of human beings include 
the superoxide anion (O2
-
), hydrogen peroxide 
(H2O2), hydroxyl radical (OH
-
), and the reactive 
nitrogen species peroxynitrite (ONOO
−
), which 
have been regarded as a nasty, life-threatening, 
and destructive oxygen-derived toxicant 
(Virdiset al., 2012). In ideal conditions, ROS 
generation is tightly regulated by endogenous 
cellular antioxidants, which include superoxide 
dismutase (SOD), catalase, thioredoxin, 
glutathione, and antioxidant vitamins. In 
physiological conditions, the rate of ROS 
generation is counterbalanced by the rate of 
elimination. In contrast, under pathological 
conditions, ROS are produced in concentrations 
that cannot be matched by protective antioxidant 
mechanisms in the cells, when this happens, a 
state of oxidative stress ensues (Landmesser and 
Harrison, 2001).  This research is therefore 
designed to assess the effect of smoking on 
markers of oxidant status and then, the clinical 
effect, if any, on existing hypertension. 
 
MATERIALS AND METHODS  
Inclusion and Exclusion Criteria: The criteria 
of selection of subjects (either smoking or non-
smokinghypertensives) were that no one should 
have any clinical condition which could result in 
hypertension such as diabetes or any other 
disorder. Hence, all subjects included in the 
present study are type I hypertensives.  
Blood samples: Fasting blood samples (10 ml) 
were collected from subjects and controls under 
aseptic precautions by Venepuncture. 5 ml of the 
blood samples wereplaced in heparinized tubes 
for SOD estimations, the remaining 3.0 ml was 
dispensed into a plain tube for 
serumThiobarbituric acid reactive substances 
(TBARS) determination. It was allowed to clot.  
Samples were centrifuged as soon as possible at 
12000 rpm for 10 min at 4°C. Serum samples for 
TBARS were stored at −70°C until the time of 
analysis. After separating the plasma from the 
heparinized tubes, erythrocytes were washed 
three times in normal saline and were 
heamolysed by dilution in water and stored at 
−20°C until used for measurement of SOD and 
CAT activities 
Determination of Biochemical Parameters  
TBARS as a marker for lipid peroxidation and 
therefore oxidative stress, was determined using 
the thiobarbituric acid (TBA) method of Okhawa 
et al., (1979). 
Erythrocyte SOD activity was assessed 
according to the method of Marklund and 
Marklund, (1979) which is based on the ability of 
SOD to inhibit auto-oxidation of pyrogallol. One 
unit of SOD being the activity of enzyme 
required to inhibit the auto-oxidation of 
pyrogallol by 50% in the assay mixture.The 
results are expressed in units/gHb. 
Blood pressure was measured using a digital 
sphygmomanometer (Omros, Japan) according to 
manufacturer’s guidelines.  
Determination of blood pressure  
The subjects were instructed to abstain from 
exercise, smoke or consumption of foods or 
drinks containing caffeine (such as tea or coffee) 
for at least 30 minutes before measurement 
Blood pressure was done in duplicates at an 
interval of at least one minute between readings. 
The average value of the two readings was 
calculated. This value is taken to be the systolic 
and diastolic blood pressure. In case of the two 
readings on a subject differing by more than 5 
mmHg, one additional reading was obtained 
before the average was taken.  
Statistical analyses: Results were expressed as 
mean and standard deviation (SD). Statistical 
analysis was carried out using the SPSS program. 
All values are expressed as mean±SD and were 
found to be significant or otherwise at P<0.05 
(version 17.0 software, SPSS Inc. Chicago, 
Illinois, USA 
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RESULTS 
Table 1: Population, age, sex and values(mean±SD) of all estimated parameters 
_______________________________________________________________________ 
Parameters                     Group I                                Group II                              Control 
              Hypertensive smokers        Hypertensive Non smokers          Healthy non smokers 
_____________________________________________________________________________ 
Population               36                                    47                                      22 
Age(Years)                    43.11 ± 6.71                  47.24 ± 11.19                  35.27 ± 8.39 
Sex (f/m)                       0/36                                8/39                                  5/17 
TBARS (nmol/L)         4.46 ± 1.13                     3.62 ± 0.81                      1.98 ± 0.47  
SOD(U/gHb)               931.66 ± 188.12            1198.47 ± 125.19           1491.04 ± 164.83 
Diastolic BP                  97.72 ± 10.07              94.19 ± 13.61                  77.32 ± 6.73 
Systolic BP               149.81 ± 14.72              142.15 ± 11.34                    116.29 ± 5.16    
__________________________________________________________________________  
 
Table2: Hypertensive smokers versus control 
_____________________________________________________________________________________ 
Variables  Hypertensive            Control        Student’s  t                 P value    
   Smokers                            (Critical t= 2.0032) 
_____________________________________________________________________________________ 
TBARS(nmol/ml)         4.46 ± 1.13     1.98 ± 0.47                  9.7642  .0000  
SOD(U/gHb)  931.66 ±188.12        1491.04 ±164.84        11.5179                .0000 
Systolic BP(mmHg) 149.81 ± 14.72         77.32 ± 6.73                9.6592  .0000 
Diastolic BP(mmHg) 97.72 ± 10.07            116.29 ± 5.16             8.4091  .0000 
____________________________________________________________________________________ 
  
 
Table 3: Hypertensive non smokers versus control 
____________________________________________________________________________ 
Variables  Hypertensive              Control          Student’s t                P value    
   Non smokers                                      (Critical t= 1.9960) 
_____________________________________________________________________________________ 
TBARS(nmol/ml)         3.62 ± 0.81                  1.98 ± 0.47  8.8065  .0000 
SOD(U/gHb)  1198.47 ± 125.19       1491.04 ± 164.83 8.1750    .0000 
Systolic BP(mmHg)  142.15 ± 11.34           116.29 ± 5.16          5.4925  .0000 
Diastolic BP(mmHg)    94.19 ± 13.61             77.32 ± 6.73                    9.3959      .0000 
_____________________________________________________________________________________ 
 
Table 4: Hypertensive smokers versus non hypertensive smokers 
_____________________________________________________________________________________ 
Variables  Hypertensive       Hypertensive          Student’s t                 P value    
      smokers              Non smokers    (Critical t= 1.9897) 
_____________________________________________________________________________________ 
TBARS(nmol/ml)         4.46 ± 1.13              3.62 ± 0.81                 3.9448  .0002 
SOD(U/gHb)  931.66 ± 188.12     1198.47 ± 125.19 7.7451  .0000 
Systolic BP(mmHg) 149.81 ± 14.72       142.15 ± 11.34           2.7040  .0009 
Diastolic BP(mmHg)   97.72 ± 10.07         94.19 ± 13.61                 2.6790  .0083 
______________________________________________________________________________ 
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Figure I: Erythrocyte SOD activity in all groups 
 
Figure II: TBARS levels in all groups 
 
Table 1: Age, sex, population, mean ± SD of 
parameters estimated (TBARS, SOD, systolic and 
diastolic blood pressure). 
Table 2, Figure I and II: Statistical comparison of 
values of all parameters between hypertensive 
smokers and control. There were statistically 
significant variations (P<0.0001) when all parameters 
in hypertensive smokers were compared with that of 
normal non smokers. 
Table 3, Figure I and II: Statistical comparation of 
values of all parameters between hypertensive non 
smokers  and control. There were statistically 
significant variations when all parameters in 
hypertensive non smokers were compared with that of 
normal non smokers. 
Table 4, Figure I and II: Statistical comparison of 
values of all parameters between hypertensive 
smokers and hypertensive non smokers. All values 
were found to be statistically significant when all 
parameters in hypertensive smokers were compared 
with that of hypertensive non smokers. 
DISCUSSION 
The pathophysiology of hypertension involves an 
increased peripheral resistance, resulting 
predominantly from functional, structural, and 
mechanical alterations at the level of small-
resistance arteries (Virdiset al., 2011). These 
alterations could include an impaired endothelial 
function, vascular remodeling secondary to an 
increased cell growth, cell migration, and to a 
lesser extent, vascular inflammation resulting in 
the narrowing of the lumen(Schiffrin, 
1992;Mulvany et al., 1996). Smoking has been 
described as a cocktail of danger by many 
researchers (Navas-acien et al., 2004;Torikai et 
al., 2004; Proctor, 2012), contaminating the 
smoker with so many harmful substances that has 
carcinogenic and other toxic dimensions on the 
human physiology. The systolic blood pressures 
is that due to the pumping effect of the heart 
when it beats, while the diastolic blood pressure 
is the pressure in the arteries when the heart rests 
between beats and, is therefore a reflection of the 
reaction of the blood vessels to the flow of blood. 
In this research there was a statistically 
significant difference when both the systolic and 
the diastolic blood pressures in hypertensive 
smokers were compared with that of non 
smokers. Similarly, both the systolic and 
diastolic blood pressure was significantly higher 
in hypertensive nonsmokers. This research also 
compared values of hypertensive smokers with 
that of hypertensive non smokers. Thus, both the 
systolic and the diastolic blood pressure in 
hypertensive smokers were significantly higher 
than that seen in non smoking hypertensives, 
giving an indication that the use and misuse of 
tobacco products has significant effects on the 
pumping force of the heart and also on the 
reaction of the arteries to the flow of blood. 
Though this findings links hypertension and 
smoking, it begs for further probe, as 
hypertension is a clinical manifestation of 
molecular and cellular interactions within the 
vasculature  (Schiffrin, 1992; Mulvany et al., 
1996), to which smoking as a lifestyle is a likely 
contributing factor (Navas-acien, 2004). 
TBARS was measured to reflect the extent of 
lipid peroxidation. Its inclusion in this research 
was predicated on the fact that any substance that 
will promote the pathogenesis of hypertension 
may do so through artherogenesis, fatty streak 
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atherosclerosis) formation being a sequel of lipid 
peroxidation (Vogiatzi et al., 2009). Lipid 
peroxidation was found to be significantly higher 
when both hypertensive smokers and non 
smoking hypertensives (Tables 2 and 3,Fig II) 
were compared with normal non smokers. Lipid 
peroxidation was also significantly increased in 
hypertensive smokers when compared with 
hypertensive non smokers (Table 4, Fig. II), 
giving an indication that smoking exacerbates 
lipid peroxidation in both hypertensive and 
normal smokers. Superoxide dismutase (SOD) is 
an antioxidant enzyme. Among the known 
antioxidant proteins,  (SOD) is thought to play a 
central role because of its ability to scavenge 
superoxide anions, the primary ROS generated 
from molecular oxygen in cells (Fridovich, 
1995), that it has been thought of as the body’s 
firstline of defense against oxidative damage 
(Recklies et al., 2000). In this research, there is a 
significant reduction in SOD activity when both 
smoking and non smoking hypertensives were 
compared with non smoking normotensives 
(Tables 2 and 3, Fig. 1), making it evident that 
hypertension is associated with reduced 
antioxidative SOD activity. Similarly, SOD 
activity was significantly lower in smoking 
hypertensives when compared with non smoking 
hypertensives (Table 4, Fig. 1) indicating that 
smoking is associated with the depletion of SOD 
activity and the reason could not be farfetched; 
Smokers are exposed to so many harmful 
substances, for example, cigarette smokers are 
contaminated through cigarette with nicotine and 
also heavy metals such as lead, cadmium, arsenic 
and mercury. Halimi et al., (1998) stated that 
smoking is associated with an acute increase in 
arterial pressure due to systemic 
vasoconstriction, decreased skin and coronary 
blood flow, nicotine being associated with the 
cardiovascular effect. As regards the deleterious 
effects of the heavy metals, SOD is a 
metalloenzyme, upon contamination with any of 
the heavy metals mentioned above, they are 
likely to replace Cu, Mn and Zn as the metal 
constituents of SOD (Huang et al., 2006). When 
this happens the enzyme activity is diminished, 
therefore the level of the superoxide, which 
should have been scavenged increases, leading 
to, among other conditions, accelerated lipid 
peroxidation..When anti oxidant levels decrease, 
the superoxide ion accumulates in the system, 
leading to the development and progression of a 
variety of cardiovascular diseases (Touyz et al., 
2003; Navas acien et al., 2004; Touyz and 
Schifrin., 2004). In fact this is the summary as 
explained in the works ofriendlinget al., (2000) 
and landmesser and Harrison (2001), of the ways 
by which ROS perform their pathophysiological 
role in cardiovascular dysfunction associated 
with several clinical conditions.As HTN is a 
major independent risk factor for coronary artery 
disease, stroke, and kidneyfailure(Tabassum and 
Ahmad, 2011), if there is any truth in the saying 
in the work of Tabassum and Ahmad, 2011 
that“each increase of 20 mmHg in systolic BP 
and 10 mmHg in diastolic BP, over therange of 
115/75 to 185/115 mmHg, doubles the risk of a 
fatal coronary event”, then the significant 
increase in both the systolic and diastolic BP of 
the hypertensive smoker over thenon smoking 
hypertensive subjectsgives the indication that 
smoking as a lifestyle aggravates an already 
existing hypertensive state. In fact, there is a 
possibility that hypertensive smokers are being 
undercared for, if given the same set of 
treatments as the non smoker. 
CONCLUSION 
This research found that smoking exposes these 
subjects under examination to substances which 
directly or otherwise increase blood pressure. 
Thus,increased lipid peroxidation and reduced 
antioxidant enzyme activity as seen in 
hypertensives when compared with control and 
when hypertensive smokers was compared with 
hypertensive non smokers proves further that 
reduced antioxidant status, smoking and, 
elevation of blood pressure, are interrelated. It 
appears smoking is a contributing factor to the 
generation of reactive oxygen species, hence the 
classical peculiarities of hypertension. 
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